Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score
Psychiatric Times
JUNE 13, 2025
Yet, she expressed that the moderate eye blinking and mild lip movements were impacting her job, emotions, self-esteem, and social functioning, causing significant distress, so she readily agreed to initiate VMAT2 inhibitor treatment to minimize these movements to the greatest degree possible. Teva Pharmaceuticals; 2025.
Let's personalize your content